Senior executive growing global, sustainable businesses to 10x revenue and profits from stagnant or net loss situations. Have a 14-year record of leading new and troubled businesses from start-up to $200M; in diverse industries and company sizes; with up to 60% customers outside the US. ● “Not all market opportunities are created equal.” Passionate in building businesses that solve the most critical problems for customers. Instill disciplined “listen-first,” customer-problem focus in a business to identify and validate strategies. ● Being co-inventor of the world's first wafer inspection system for KLA and having seen this grow to a $1B business, have become savvy in creating collaborative partnerships with key technologists to match solutions to the right market opportunity. Time and money is wasted when technology does not solve big enough problems. ● Build high-functioning leadership teams from siloed execution to strategic alignment across the business for highest value creation. Wrong leadership and poor execution will drive a business to failure – and losing critical "brain power" in the process! Specialties: General Management, startups, turnarounds, inflection points. Improve EBITDA, revenue. Business, marketing strategy. Leadership, mentoring, coaching, change management. Software, SaaS, imaging, medical instruments, medical device, health tech, genomics tools, healthcare IT, capital equipment. M&A & integration. Technology roots in optics, x-ray, image processing, SPECT, MRI, metrology, inspection. Lean Product Development. International - China, India, Taiwan, Israel, Japan.

Senior VP, Research & Development @ Medrobotics has developed a platform of flexible medical robots that enable surgeons to access, visualize, and perform two-handed surgery in hard-to-reach anatomical places through a single-site access. The core technology is a new generation of flexible robotic snakes with advanced vision systems that are able to navigate tortuous paths while providing accessory channels for a wide range of flexible surgical tools. The robots are self-supporting, which means they are able to support their own weight and move within any three-dimensional space without the need for any other structural support. Medrobotics has exclusive worldwide licenses for its technologies from Carnegie Mellon University as well as additional robust development of its own intellectual property portfolio. www.medrobotics.com From 2014 to Present (1 year) Greater Boston AreaOperating Partner @ Tech-Rx rescues early-stage high-tech and med-tech companies in crisis by investing new capital combined with active, hands-on management. We are the first to apply the private equity model to early-stage companies. See Tech-Rx Article in Venture Beat: http://venturebeat.com/2013/01/15/startup-falling-apart-silicon-valleys-fairy-godfathers-are-at-your-service/ From March 2013 to Present (2 years 10 months) San Francisco Bay AreaInterim COO, CTO and Business Advisor @ Chief Operating Officer, Chief Technical Officer and business advisory expertise for companies at critical inflection points. Providing ongoing consulting (as requested) to Tech-Rx and SciMed Partners (below). ● Acting VP R&D, MEDROBOTICS, Inc., (2013 – 2014). Leading the development of an innovative surgical robotics platform with a technology spun out of Carnegie Mellon University. www.medrobotics.com ● Interim COO, NOVARAY MEDICAL, Inc., (2011 – 2014). Support the CEO in fundraising and operations for commercialization for this medical imaging company in cardiac angiography. Enabled successful fundraise and partnership with a strategic Beijing-based medical imaging company. www.novaraymedical.com ● Business advisor, INTERCONNECT MEDICAL, Inc., (2012 – 2014). Early-stage healthcare IT company focusing on curbside medical consulting. www.image32.com ● Business Advisor, PREDICTIVE MEDICAL TECHNOLOGIES, Inc., (2010 – 2013). Early-stage pioneer of real-time, predictive diagnostics for adverse outcomes for patients in the intensive-care-unit. www.predictive-medical.com ● Strategic Advisor, INSTREAM PARTNERS, LLC (former Via Incorporated), (2010 – 2014). Instream provides corporate finance and mergers & acquisitions services to public & private technology growth companies. www.instreampartners.com From 2011 to 2014 (3 years) San Francisco Bay AreaSenior Consulting Partner, Medical Tech, Diagnostics and Imaging @ SciMed Partners helps companies, investors, and entrepreneurs assess markets, technologies, and intellectual property with a wide variety of services in the scientific and medical arenas. Our goal is to foster innovation and help companies emerge and disrupt the marketplace. Our focus is in medical devices and healthcare technologies, biotechnology, pharmaceuticals, and emerging technologies. We’re strategically located in one of the world’s centers of innovation, the San Francisco Bay Area and Silicon Valley with a satellite office in Charlotte, NC. From February 2013 to 2013 (less than a year) San Francisco Bay AreaPresident and CEO @ Early-stage medical software company with predictive biomarkers for multiple sclerosis and other important diseases. Brought in by the founder to lead development of the company. ● Assembled seasoned executive team and luminary board to position company to raise institutional funding in extremely distressed financial environment. ● Raised bridge financing, executed market study to layout coherent "Go-to-market" strategy for investors. From 2008 to 2011 (3 years) San Francisco Bay AreaGeneral Manager, WW SPECT Business Unit, Nuclear Medicine @ SPECT was a $150M+ business within Philips Medical. Brought in to lead the turnaround of this global business stagnating after M&A. ● Drove the team to complete and introduce a 1st generation platform to garner double-digit $M backlog by first install. Customers raved it "best product in 11 years" and won 2nd place as Aunt Minnie’s "Best New Radiology Device." ● The 2nd generation product propelled the business to profitability and market share expansion and growth of 22% to 60% (US), 40% (WW). From 2006 to 2008 (2 years) San Francisco Bay AreaVP, Officer, Engineering & Informatics @ $25M bio-informatics start-up providing genomic information services to pharma companies. Recruited to consolidate and integrate all engineering and operations functions. ● Led technology deployment of operations in Japan to support transfers to the US of 30 GB/day. From 2004 to 2006 (2 years) San Francisco Bay AreaBoard Member @ Brought on as an active Board Member to lead the negotiation and sale of this life science tools company. Became Iteration Four after sale. Concurrent with Perlegen Sciences and Philips Healthcare. www.norgrensystems.com ● Hired CEO and together successfully exited the business with excellent valuation. From 2004 to 2006 (2 years) San Francisco Bay AreaVP, General Manager @ KLA was the leading supplier of yield management solutions that grew from $300M to $1.4B (after merging with Tencor). ● Successively led diverse (software, integration services, equipment and OEM) global divisions with increasing scope up to $40M. ● Recruited by the CEO, led the startup "Thin Films Inspection" business. This successful product line catalyzed the merger of KLA and Tencor. ● Took over a $10M OEM division and turned this business around from sporadic, marginal profitability to yield consistent 35% EBITDA. ● Led the entire software business, acquiring 3 businesses in 2½ years and turned around this $33M software division from -30% to positive EBIDTA and grew revenue to $40M. ● Transformed the software-services business from -90% to 40% gross margin and profitability, boosted revenue to $4 M/year within 1 year, and achieved 14% EBITDA. From 1995 to 2003 (8 years) San Francisco Bay AreaVP, Officer, Engineering @ Molecular Dynamics was a genomics-tools start-up; which IPOed in 1994. www.gelifesciences.com ● Led engineering and boosted revenue from $10M to $50M in 4 years. ● Built an engineering culture that was extremely focused on external, market metrics and customer-focused to drive rapid development. Engineering became a powerhouse of execution, developing 16+ successful equipment/software products. From 1990 to 1995 (5 years) San Francisco Bay AreaVP, Business Unit Manager, Metrology @ KLA was capital equipment startup, which grew to over $150M. ● Recruited by the CEO to turnaround a faltering $6M global business in US, Europe and Asia. ● Recognizing that the technology solution to the market addressed was running out of gas, led team to identify an adjacent market to reposition the business and drove focus on reliability and customer issues. In just 3 years, the business grew from 5 to 55% to achieve positive EBITDA for the first time and became a $100M+ division within KLA-Tencor. From 1989 to 1990 (1 year) San Francisco Bay Area

MS and PhD, Electrical Engineering @ University of Illinois at Urbana-ChampaignB.Eng., Electrical @ Pratt InstituteCertificate, Management of High Technology Companies, AEA | Stanford University Executive Institute @ Stanford University Graduate School of Business Russell Singleton is skilled in: General Management, Global Business Management, Business Change Management, Business Turnaround, Grow Businesses, Reposition Businesses, Business Strategy, Leading transformational change, Lean Thinking, M&A experience, Start-ups, EBITDA Growth, Business, Change Management, Digital Imaging